Streetbeat News

Stock Prices

ONCY

Oncolytics Biotech Inc. (NASDAQ:ONCY) announced that CEO Dr. Matt Coffey will take a medical leave of absence, with Wayne Pisano, Chair of the Board, stepping in as interim CEO. Pisano has extensive experience in the pharmaceutical and biotech industries, including leadership roles at Sanofi Pasteur and VaxInnate.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:08 am

HRMY

Harmony Biosciences has received FDA approval for a supplemental new drug application for WAKIX, which is expected to enhance its market position and potentially increase revenues.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:05 am

AXGN

Axogen, Inc. (NASDAQ:AXGN) has launched a new product, Avive+ Soft Tissue Matrix, designed to aid in nerve healing. This product is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing. The product complies with FDA regulations and aims to address a significant need in the $800 million nerve protection market.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:03 am

ALNY

Alnylam Pharmaceuticals announced positive topline results from its HELIOS-B Phase 3 study of Vutrisiran. The study achieved statistical significance on both primary and all secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:02 am

EFTR

eFFECTOR Therapeutics has announced plans to wind down its operations and seek potential strategic alternatives. The company also expects to delist from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:01 am

ALNY

Trading in ALNY was halted at 6:55:00 a.m. ET pending news. Investors should stay tuned for updates as the halt indicates significant news is forthcoming.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:55 am

BA

ITA

PPA

Boeing Co (NYSE:BA) risks potential criminal charges as U.S. prosecutors reportedly recommend legal action against the company for allegedly breaching a 2021 deferred prosecution agreement following two fatal 737 MAX crashes. The Justice Department has until July 7 to decide on prosecuting Boeing, which could result in significant penalties. Boeing has denied any wrongdoing, but discussions with the Justice Department are ongoing. The stock has lost more than 14% in the last 12 months. Investors can gain exposure to Boeing via IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Invesco Aerospace & Defense ETF (NYSE:PPA).

Portfolio Pulse from Shivani Kumaresan

June 24, 2024 | 10:47 am

TSLA

Elon Musk has called for legal reform on class action lawsuits, arguing that they often do not represent shareholders and primarily benefit law firms. This comes in light of a lawsuit that led to the revocation of his 2018 pay package, which was recently re-approved by Tesla shareholders.

Portfolio Pulse from Anan Ashraf

June 24, 2024 | 10:44 am

NXE

NexGen Energy's Rook I Project is advancing as the Canadian Nuclear Safety Commission (CNSC) reviews the final Environmental Impact Statement (EIS). The CNSC has started a 60-day technical review, after which a Federal Commission Hearing date will be set. NexGen is ready to commence major construction upon receiving the remaining approvals.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:37 am

ADRT

GIGA

Gresham Worldwide, Inc. (OTCQB:GIGA) and Ault Disruptive Technologies Corporation (NYSE:ADRT) have announced a merger agreement. The transaction, valued at approximately $83 million, will see Gresham redomicile to Delaware and rebrand as Gresham Worldwide, Inc., listed on the NYSE American under the ticker symbol 'GWWI'. The merger aims to expand Gresham's defense and healthcare technology capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:35 am